Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor α agonist in preclinical species and human
Frederick, K.S., Maurer, T.S., Kalgutkar, A.S., Royer, L.J., Francone, O.L., Winter, S.M., Terra, S.G., Chen, D., Gao, X.
Published in Xenobiotica (01.10.2009)
Published in Xenobiotica (01.10.2009)
Get full text
Journal Article
The discovery of CP-230,821, upregulator of the LDL receptor, for the treatment of hypercholesterolemia
Chang, G., Cummings, D.S., Gillaspy, M.L., Barbacci-Tobin, E.G., Bourassa, P.A., Long, C.A., Royer, L.J., Aiello, R.J., Hayes, L.S., Lira, M.E., Lloyd, D.B., Milos, P.M., Thompson, J.F.
Published in Atherosclerosis (1994)
Published in Atherosclerosis (1994)
Get full text
Journal Article